The Pharma Letter Biotechnology_Petri DishBIOTECHNOLOGY looks at news relating to biotech companies, their financial performance, licensing, research and merger & acquisition activities. Read wide ranging reports from around the globe, backed by a massive archive from which developments in different areas can be tracked. At this time of new legislation and activities in the area of “biosimilars: or “biogenerics” approvals, which have progressed more in Europe and are likely to impact the huge US market quite soon, watching this area will be an important aspect for subscribers and those active in the sector.

Latest Pharma Letter Articles

Biotechnology

features_upload

European and international experts prepare for the evaluation of future nano-medicines

7 September 2010

The European Medicines Agency (EMEA) hosted the first international scientific workshop on

Seattle Genetics gets milestone as Astellas unit moves cancer drug into Ph I

3 September 2010

US biotechnology firm Seattle Genetics (Nasdaq: SGEN) has achieved a milestone under its antibody-drug

US Justice Dept appeals ruling against embryonic stem cell research

2 September 2010

The USA’s Department of Justice has appealed a district judge's ruling to ban federal funding

PDL BioPharma sues Roche’s Genentech over royalties

2 September 2010

US drug developer PDL BioPharma (Nasdaq: PDL) said yesterday that it has filed suit in a Nevada

Lonza acquires viral vaccine and vector manufacturer Vivante GMP Solutions

1 September 2010

Switzerland’s active pharmaceutical ingredients and specialty chemicals firm Lonza (LONN.VX)

Genzyme snubs Sanofi-Aventis’ $18.5 billion offer; French drugmaker reports good data for MS drug teriflunomide

31 August 2010

It was a bad and a good news day yesterday for French drug major Sanofi-Aventis (Euronext;

Biotechnological Cracow

6 September 2010 | Polish Market

Biotech IPO to target key ailments as Australia ages

6 September 2010 | Sydney Morning Herald

Cancer drug trial halted as patients fall ill

2 September 2010 | Financial Times

XOMA Regains NASDAQ Compliance

2 September 2010 | MarketWatch (press release)